KIC
RMD icon

Kensington Investment Counsel’s ResMed RMD Stock Holding History

Kensington Investment Counsel’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$813K Sell
4,172
-106
-2% -$22K 0.35% 57
2026
Q1 		$960K Sell
4,278
-1,741
-29% -$434K 0.46% 47
2025
Q4 		$1.45M Sell
6,019
-694
-10% -$177K 0.59% 48
2025
Q3 		$1.84M Sell
6,713
-385
-5% -$105K 0.75% 42
2025
Q2 		$1.83M Sell
7,098
-29
-0.4% -$6.92K 0.79% 41
2025
Q1 		$1.6M Sell
7,127
-137
-2% -$32K 0.71% 47
2024
Q4 		$1.66M Sell
7,264
-33
-0.5% -$7.95K 0.69% 48
2024
Q3 		$1.78M Buy
7,297
+25
+0.3% +$5.59K 0.74% 47
2024
Q2 		$1.39M Sell
7,272
-2,798
-28% -$568K 0.62% 50
2024
Q1 		$1.99M Buy
10,070
+704
+8% +$129K 0.91% 41
2023
Q4 		$1.61M Buy
9,366
+133
+1% +$20.4K 0.84% 40
2023
Q3 		$1.37M Buy
9,233
+3,784
+69% +$684K 0.85% 43
2023
Q2 		$1.19M Sell
5,449
-82
-1% -$18.3K 0.75% 47
2023
Q1 		$1.21M Sell
5,531
-548
-9% -$119K 0.91% 46
2022
Q4 		$1.27M Hold
6,079
– – 0.99% 45
2022
Q3 		$1.33M Buy
6,079
+34
+0.6% +$7.74K 1.12% 43
2022
Q2 		$1.27M Sell
6,045
-142
-2% -$30.2K 1.08% 41
2022
Q1 		$1.5M Sell
6,187
-682
-10% -$165K 0.99% 48
2021
Q4 		$1.79M Buy
+6,869
New +$1.78M 1.04% 45
2021
Q2 		$1.47M Buy
5,945
+141
+2% +$29.6K 1.01% 49
2021
Q1 		$1.13M Buy
5,804
+380
+7% +$76.2K 0.85% 58
2020
Q4 		$1.15M Buy
+5,424
New +$1.08M 0.95% 55

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kensington Investment Counsel's RMD Position: Q2 2026 in Review

Kensington Investment Counsel reduced its ResMed (RMD) stake by 2.5% in Q2 2026, selling an estimated $22K and leaving 4,172 shares worth $813K. The position accounts for 0.35% of the portfolio, ranked #57.

Kensington Investment Counsel first reported a position in RMD in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.99M in Q1 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Kensington Investment Counsel held 4,172 shares of ResMed worth $813K as of Q2 2026.
  • Kensington Investment Counsel sold 106 ResMed shares in Q2 2026, an estimated $22K.
  • ResMed made up 0.35% of Kensington Investment Counsel's portfolio in Q2 2026, its #57 holding.
  • Kensington Investment Counsel first reported a position in ResMed in Q4 2020 and has held it in 22 quarters since.
  • Kensington Investment Counsel's ResMed position peaked at $1.99M in Q1 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Kensington Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.